|
Dr. Scolnick has been a Director of Millipore since 2001 and is currently Chairman of the Technology Committee.
Dr. Scolnick received his A.B. Degree from Harvard College in 1961 and his M.D. from Harvard Medical School in 1965. From 1967 to1970 Dr. Scolnick served in several research capacities at the National Heart Institute. In 1970 he joined the National Cancer Institute as a Senior Staff Fellow and held positions of increasing responsibility: Head of the Genetics Section (1971to1975) and Chief Laboratory of Tumor Virus Genetics and Head of the Molecular Virology Section (1975 to1982).
In 1982 Dr. Scolnick joined Merck & Co. Inc. a global research-driven pharmaceutical company as Executive Director of Basic Research Virus & Cell Biology Research of the Company’s Research Laboratories becoming Vice President Virus and Cell Biology Research in 1983. In 1984 Dr. Scolnick became Senior Vice President Research and Senior Vice President of Cell Biology Research. In 1985 Dr. Scolnick became President of Merck Research Laboratories and Senior Vice President of Merck & Co. Inc. serving in both capacities until his retirement in December 2002 when he chose to renew his work as a research scientist.
He also served as Executive Vice President Science & Technology of Merck & Co. Inc. from 1993 and as a Director of Merck & Co. Inc. from 1997 until December 2002. Dr. Scolnick retired from Merck Research Laboratories in September 2004. On September 1 2004 Dr. Scolnick became an Associate Member of the Broad Institute a research collaboration of the Massachusetts Institute of Technology Harvard University and its hospitals and the Whitehead Institute for Biomedical Research and became a Senior Associate Member on September 1 2006.
Dr. Scolnick has received numerous academic appointments and was Frank H.T. Rhodes Class of '56 visiting professor at Cornell University and Regents Lecturer University of California Berkeley. He has also authored or co-authored a number of scientific papers on virus and cell biology research. He is a Member of the National Academy of Sciences and its Institute of Medicine. Dr. Scolnick is also a member of the Board of Directors of: McLean Hospital; McGovern Institute for Brain Research; and Alinea Pharmaceuticals Inc. He is also a Senior Scientific Advisor to MPM Capital a global asset management firm focused on health care investments. | 